Establishment Labs(US:ESTA) Seeking Alpha·2026-01-14 20:56Company Overview - Establishment Labs is a medical technology company focused on breast aesthetics and reconstruction, emphasizing innovation to enhance women's health and well-being [2] - The company has been operational for 20 years, selling over 4.5 million devices across 90 countries [3] Recent Performance - Establishment Labs reported a 27% growth on a global basis for the year 2025, indicating strong market performance [3] - The company successfully launched its products in the U.S. after receiving FDA approval at the end of 2024, achieving a strong start in its first year [3] Future Outlook - Establishment Labs is well-positioned for significant growth in 2026 and beyond, with a focus on science-based innovation that sets a new standard in the breast aesthetics and reconstruction market [2][3]